Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Performance status" patented technology

In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general well-being and activities of daily life. This measure is used to determine whether they can receive chemotherapy, whether dose adjustment is necessary, and as a measure for the required intensity of palliative care. It is also used in oncological randomized controlled trials as a measure of quality of life.

A Multi-Dimensional Health Status Assessment Method for Equipment Based on Bulldozer Distance Measurement

ActiveCN115841260BReal-time dataTime data
This invention discloses a multi-dimensional health status assessment method for equipment based on bulldozer distance measurement, which uses monitoring parameters (also known as monitoring data) that characterize the equipment's performance status as input. The method includes: first, preprocessing the full-lifecycle data and real-time data to improve data usability; then, performing a weighted average of degradation-sensitive parameters with the same direction of inversion, determining a standard health set using the health status sample sets of the full-lifecycle data and real-time data, and determining a standard fault set using the fault status sample set of historical data; then, calculating the bulldozer distance through a time-series sliding window to obtain a performance degradation sample set; and finally, linearly generating the equipment health status set.
Owner:BEIHANG UNIV

Mycobacterium for use in cancer therapy

ActiveUS12673074B2RegimenChemotherapy combinations
This invention provides an immunomodulator for use in the treatment, reduction, inhibition or control of cancer subject, wherein the subject is clinically classified as having a performance status of 1-, 2, 3 or 4 according to the ECOG Scale, or classified as not being of an age and / or not being sufficiently fit to tolerate two or more chemotherapy regimens. The invention also describes the use of one or more additional anticancer treatments or agents as well as protocols and dosage regimens for use.
Owner:IMMODULON THERAPEUTICS